The Chicago Entrepreneur

FDA approves Bristol Myers Squibb’s schizophrenia drug, the first new type of treatment in decades

The twice-daily pill, Cobenfy, is a badly needed new treatment option for the nearly 3 million adults in the U.S. living with schizophrenia. 

Leave a Reply

Your email address will not be published. Required fields are marked *

Previous post Hut 8 eyes AI push with launch of GPU-as-a-service program
Next post China ETFs set for best week on record after Beijing fires policy ‘bazooka’ to boost economy. Is it time to jump in?